Consultant gastroenterologist at the Royal Liverpool University Hospital
United Kingdom
Dr. Andrew Robert Moore, a consultant gastroenterologist and general physician, brings a wealth of expertise to his role at the Royal Liverpool University Hospital. Holding a PhD in Gastroenterology/Physiology from the University of Liverpool, Dr. Moore's extensive education underpins his specialization in upper gastrointestinal cancer, preneoplasia, and neuroendocrine tumor disease management. With leadership roles in upper GI disease and endoscopy services, Dr. Moore oversees clinics, trains medical professionals, and conducts research, contributing significantly to advancements in gastroenterological care.
Dr. Andrew Robert Moore is a British consultant gastroenterologist and general physician affiliated with the Royal Liverpool University Hospital, where he has served since September 2015. He obtained his Bachelor of Medicine and Bachelor of Surgery (MBChB) with commendation from the University of Liverpool, later pursuing a PhD in Gastroenterology/Physiology from the same institution. Dr. Moore is also a Member of the Royal College of Physicians. He completed his specialist training in Gastroenterology under the Mersey Deanery, obtaining certification in May 2015. His experience extends to more than 20 years.
Dr. Moore's clinical interests predominantly revolve around upper gastrointestinal cancer and preneoplasia, advanced upper GI endoscopy, and the management of neuroendocrine tumor disease. He has demonstrated a commitment to advancing medical knowledge through clinical research, having led a phase 2 clinical trial and acted as a local investigator for national trials. Dr. Moore's involvement in various professional committees, including the British Society of Gastroenterology, showcases his dedication to advancing gastroenterological care nationally.
As the clinical lead for upper GI disease at Royal Liverpool University Hospital, Dr. Moore oversees specialist tertiary and general upper GI clinics, demonstrating leadership in patient care. Additionally, he leads the hospital's endoscopy service, overseeing a large unit and training registrars and non-medical endoscopists. Dr. Moore's expertise extends to neuroendocrine tumor management, where he is a member of the supraregional neuroendocrine tumor multidisciplinary team.
Throughout his career, Dr. Moore has contributed significantly to research in gastroenterology, with numerous publications in peer-reviewed journals and presentations at national and international conferences. His research spans topics such as gastric neuroendocrine neoplasms, eosinophilic esophagitis, and the effects of proton pump inhibitor therapy on gastric preneoplastic pathology. Dr. Moore's teaching experience includes supervising foundation doctors and higher specialist trainees, as well as serving as an examiner for undergraduate medical students at the University of Liverpool.
Dr. Moore's dedication to improving patient care is evident through his involvement in audit, quality improvement, and management projects. He has led large-scale audits resulting in research publications and actively contributes to the development of clinical protocols and services within his institution. Dr. Moore's comprehensive expertise, combined with his passion for research and education, underscores his commitment to advancing gastroenterological care and training the next generation of healthcare professionals.
Royal Liverpool University Hospital
Royal Liverpool University Hospital
NHS Trust, Mersey Deanery, UK
University of Liverpool
2015
Royal College of Physicians (London)
2006
Supraregional neuroendocrine tumour MDT - Liverpool Regional Neuroendocrine Tumour Service (LR-NETS)